Drug intelligence / Profile preview

irisflorentin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical, Bath
01

Overview

Irisflorentin is a naturally occurring isoflavone compound derived from the roots of *Belamcanda chinensis* (L.) DC., a plant used in traditional Chinese medicine. It has the molecular formula C₂₀H₁₈O₈ and molecular weight of 386.35 g/mol. The compound exhibits multiple pharmacological activities including immunomodulatory, anti-inflammatory, and neuroprotective effects. Its mechanism involves modulation of dendritic cell properties through inhibition of NF-κB and MAPK signaling pathways (specifically IKK, JNK, and p38), reduction of proinflammatory cytokine production (TNF-α, IL-6, IL-12p70), and downregulation of costimulatory molecules (CD40, CD86) and MHC class II expression. In Parkinson's disease models, irisflorentin reduces α-synuclein accumulation by enhancing proteasome activity through upregulation of the proteasome regulatory subunit rpn-3. It also demonstrates protective effects against dopaminergic neuronal degeneration and reduces nitric oxide production by inhibiting inducible nitric oxide synthase (iNOS) expression in activated macrophages.

Other names
Irisflorentine5,3',4',5'-Tetramethoxy-6,7-methylenedioxyisoflavone9-methoxy-7-(3,4,5-trimethoxyphenyl)-[1,3]dioxolo[4,5-g]chromen-8-one
02

Targets

NOS2 (Nitric Oxide Synthase 2)IL12 (Interleukin-12)IL-6 (Interleukin 6)CHUK (IKKα)NF-κBTNFA (Tumor necrosis factor alpha (soluble))JNK (Mitogen-activated protein kinase kinase kinase family)MAPK14 (p38 mitogen-activated protein kinase alpha)

Beyond the preview

Go deeper on irisflorentin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on irisflorentin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call